Collectively, our work identifies a “two birds with one stone” effect for RCOR2 in cancers and establishes a valuable framework to simultaneously target tumor cell plasticity and immunogenicity for the better treatment of human cancers. This evidence concerns the gene RCOR2 and cancer.